Bacterial sialidases subvert the complement system through desialylation
Protein Science · 2026-11 · 35 (11)
DOI: 10.1002/pro.70834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, online erschienen am 29.10.2026. Verfasst von Kurni Kurniyati und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Craniofacial Molecular Biology, Philips Institute for Oral Health Research, Virginia Commonwealth University, Richmond, Virginia, …. Hauptthemen laut MEDLINE: Neuraminidase, Complement System Proteins, Bacterial Proteins, N-Acetylneuraminic Acid. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Bacterial sialidases (neuraminidases) are widely studied virulence factors, yet their impact on the complement system, a central component of innate immunity, remains poorly understood. Here, we investigate the effects of six sialidases from five human pathogens, including Bacteroides fragilis , Clostridium perfringens , Tannerella forsythia , Treponema denticola , and Vibrio cholerae on complement immunity using an integrated approach combining genetics, biochemistry, glycobiology, mass spectrometry, and structural biology. We show that major complement proteins, including C1q, C4, and C5, as well as complement regulators Factor I, Factor H, and C4BP, are modified by terminal sialic acids (sialylation) and undergo terminal desialylation by all six sialidases. Using the oral pathogen T. denticola and its sialidase NanH as a representative model, we demonstrate that sialidase‐mediated desialylation suppresses complement activation and surface deposition, promoting complement evasion. Structural analyses of T. denticola NanH in complex with an inhibitor, sialic acid, and native glycans, together with comparisons to other sialidase structures, reveal the molecular basis of substrate recognition and catalysis. Despite substantial sequence diversity, all six exo‐ α ‐sialidases share a conserved six‐bladed β ‐propeller catalytic domain and cleave both N‐acetylneuraminic acid and N‐glycolylneuraminic acid, the predominant mammalian sialic acids. Together, these findings establish a conserved structural and functional mechanism by which diverse bacterial pathogens desialylate complement components to impair innate immune defense.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Craniofacial Molecular Biology, Philips Institute for Oral Health Research, Virginia Commonwealth University, Richmond, Virginia, USA.
- Department of Structural Biology, Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, the State University of New York, Buffalo, New York, USA.
- Proteomics and Metabolomics Facility, Institute of Biotechnology, Cornell University, Ithaca, New York, USA.
- Department of Biological Sciences, Hunter College of City University of New York, New York City, New York, USA.
ORCID-Profile: Kurni Kurniyati, Nicholas D Clark, Sheng Zhang, Michael G Malkowski, Chunhao Li
Förderung
- NIDCR NIH HHS
- NIGMS NIH HHS
- NIH HHS
- National Institute of Dental and Craniofacial Research
- National Institute of General Medical Sciences
Zitieren
APA
Kurniyati, K., Clark, N. D., Fu, Q., Zhang, S., Qiu, W., Malkowski, M. G., & Li, C. (2026). Bacterial sialidases subvert the complement system through desialylation. Protein Science, 35(11). https://doi.org/10.1002/pro.70834
Vancouver
Kurniyati K, Clark ND, Fu Q, Zhang S, Qiu W, Malkowski MG, et al. Bacterial sialidases subvert the complement system through desialylation. Protein Science. 2026;35(11). doi:10.1002/pro.70834
BibTeX
@article{Kurniyati2026,
author = {Kurniyati, Kurni and Clark, Nicholas D and Fu, Qin and Zhang, Sheng and Qiu, Weigang and Malkowski, Michael G and Li, Chunhao},
title = {Bacterial sialidases subvert the complement system through desialylation},
journal = {Protein Science},
year = {2026},
volume = {35},
number = {11},
doi = {10.1002/pro.70834}
}
EUVIMED